When canakinumab will be on the market and where can it be purchased?

Canakinumab(Canakinumab) is an interleukin-1β blocker. Canakinumab was first launched in the United States in 2009. Currently, canakinumab has not been launched in China. If patients purchase canakinumab, they can contact overseas medical consultation agencies. This medicine is available in Türkiye and costs about 9,000 yuan per box.

Inform patients of the risk of injection site reactions (e.g., pain, erythema, swelling, itching, bruising, lumps, inflammation, dermatitis, edema, urticaria, blisters, fever, bleeding). Instruct patients to inform their clinician of any ongoing injection site reactions. Inform patients of the risk of serious infection. Instruct patients to notify their clinician immediately if they develop any signs or symptoms of infection (such as fever, cough, redness of an area of u200bu200bthe body, warm or swollen skin). Instruct patients to inform their clinician if they have an active infection, a history of recurrent infection, human immunodeficiency virus (HIV), hepatitis B, or hepatitis C. It is recommended that patients with active or chronic infections not take canakinumab. Instruct patients to contact their clinician immediately if they develop signs of an allergic reaction, such as difficulty breathing or swallowing, nausea, dizziness, rash, itching, hives, palpitations, or hypotension. Advise patients to review their vaccination status with their clinician and receive all age-appropriate vaccines before initiating treatment with canakinumab. Advise patients to inform clinicians of current or anticipated concomitant therapies, including prescriptions (e.g., IL-1 antagonists such as anacla, rilonacept; tumor necrosis factor blockers such as etanercept, infliximab, certolizumab antibiotics, golimumab, or adalimumab; immunizations; corticosteroids) and over-the-counter medications, dietary supplements, or herbal products, as well as any concomitant medical conditions (such as active or chronic infections). Advise women to inform their clinician if they are pregnant or plan to become pregnant or plan to breastfeed. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.